Jens‐Peter Reese

589 total citations
18 papers, 459 citations indexed

About

Jens‐Peter Reese is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jens‐Peter Reese has authored 18 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 6 papers in Psychiatry and Mental health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jens‐Peter Reese's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Jens‐Peter Reese is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Jens‐Peter Reese collaborates with scholars based in Germany, United States and France. Jens‐Peter Reese's co-authors include Richard Dodel, Wolfgang H. Oertel, Monika Balzer‐Geldsetzer, Yaroslav Winter, Wolfgang H. Oertel, Uwe Siebert, Günther Deuschl, Judith Dams, Karel Kostev and Jens Volkmann and has published in prestigious journals such as Epilepsia, Movement Disorders and Journal of Neurology.

In The Last Decade

Jens‐Peter Reese

16 papers receiving 446 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jens‐Peter Reese 227 133 102 60 59 18 459
Rossella Musolino 133 0.6× 201 1.5× 129 1.3× 46 0.8× 125 2.1× 14 412
Giorgio Di Raimondo 220 1.0× 259 1.9× 84 0.8× 85 1.4× 48 0.8× 6 518
V. Crespi 104 0.5× 115 0.9× 71 0.7× 21 0.3× 96 1.6× 18 285
P. De Carolis 64 0.3× 265 2.0× 66 0.6× 42 0.7× 56 0.9× 31 401
Jaime L. Massucci 372 1.6× 38 0.3× 51 0.5× 64 1.1× 327 5.5× 11 781
Amy M. Smith 74 0.3× 112 0.8× 87 0.9× 16 0.3× 20 0.3× 14 309
Eugene Scharf 57 0.3× 73 0.5× 18 0.2× 47 0.8× 103 1.7× 47 495
Katrin Rauen 128 0.6× 84 0.6× 19 0.2× 27 0.5× 148 2.5× 30 438
Vida Obese 118 0.5× 58 0.4× 17 0.2× 41 0.7× 120 2.0× 12 336
Miya E. Bernson‐Leung 106 0.5× 89 0.7× 72 0.7× 86 1.4× 63 1.1× 22 429

Countries citing papers authored by Jens‐Peter Reese

Since Specialization
Citations

This map shows the geographic impact of Jens‐Peter Reese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens‐Peter Reese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens‐Peter Reese more than expected).

Fields of papers citing papers by Jens‐Peter Reese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens‐Peter Reese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens‐Peter Reese. The network helps show where Jens‐Peter Reese may publish in the future.

Co-authorship network of co-authors of Jens‐Peter Reese

This figure shows the co-authorship network connecting the top 25 collaborators of Jens‐Peter Reese. A scholar is included among the top collaborators of Jens‐Peter Reese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens‐Peter Reese. Jens‐Peter Reese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Reese, Jens‐Peter, Martin Juenemann, Michael Teepker, et al.. (2025). The impact of revised definitions on the epidemiology of status epilepticus: A population‐based study. Epilepsia. 66(11). 4298–4307.
2.
Haas, Kirsten, et al.. (2020). Versorgung von Parkinson-Patienten in Deutschland. Der Nervenarzt. 91(6). 493–502. 10 indexed citations
3.
Reese, Jens‐Peter, et al.. (2019). The association between antihypertensive therapy and the incidence of Parkinson’s disease in patients followed in general practices in Germany. International Journal of Clinical Pharmacology and Therapeutics. 57(10). 483–488. 15 indexed citations
4.
Dodel, Richard, Erika Baum, Matthias Müller, et al.. (2018). Prescription of Benzodiazepines and Related Drugs in Patients with Mild Cognitive Deficits and Alzheimer’s Disease. Pharmacopsychiatry. 52(2). 84–91. 10 indexed citations
5.
Balzer‐Geldsetzer, Monika, et al.. (2017). Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples. European Neurology. 78(3-4). 128–136. 16 indexed citations
6.
Dodel, Richard, Erika Baum, Matthias J. Müller, et al.. (2017). Use of antidementia drugs in German patients with Alzheimer’s disease. International Clinical Psychopharmacology. 33(2). 103–110. 3 indexed citations
7.
Dodel, Richard, Erika Baum, Matthias J. Müller, et al.. (2017). Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany. International Journal of Psychiatry in Clinical Practice. 22(3). 232–239. 9 indexed citations
8.
Dams, Judith, Monika Balzer‐Geldsetzer, Uwe Siebert, et al.. (2016). Cost‐effectiveness of neurostimulation in Parkinson's disease with early motor complications. Movement Disorders. 31(8). 1183–1191. 30 indexed citations
9.
Mayer, Geert, et al.. (2015). Versorgung von Schlafapnoe-Patienten in Hessen. Somnologie - Schlafforschung und Schlafmedizin. 19(3). 145–153. 1 indexed citations
10.
Dams, Judith, Uwe Siebert, Bernhard Bornschein, et al.. (2013). Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease. Movement Disorders. 28(6). 763–771. 78 indexed citations
11.
Hamer, Hajo M., Richard Dodel, Adam Strzelczyk, et al.. (2012). Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults. Journal of Neurology. 259(11). 2376–2384. 101 indexed citations
12.
Noelker, Carmen, Jens‐Peter Reese, Daniel Alvarez‐Fischer, et al.. (2012). CNI-1493 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson's Disease. Neurodegenerative Diseases. 12(2). 103–110. 11 indexed citations
13.
Winter, Yaroslav, Karsten Schepelmann, Annika Spottke, et al.. (2010). Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. Journal of Neurology. 257(9). 1473–1481. 71 indexed citations
14.
Reese, Jens‐Peter, Yaroslav Winter, Monika Balzer‐Geldsetzer, et al.. (2010). Morbus Parkinson: Krankheitskosten einer ambulanten Patientenkohorte. Das Gesundheitswesen. 73(1). 22–29. 17 indexed citations
15.
Dodel, Richard, Svenja Happe, Ines Peglau, et al.. (2010). Health Economic Burden of Patients with Restless Legs Syndrome in a German Ambulatory Setting. PharmacoEconomics. 28(5). 381–393. 23 indexed citations
16.
Winter, Yaroslav, et al.. (2009). Evaluation of costs and outcome in cardioembolic stroke or TIA. Journal of Neurology. 256(6). 954–963. 61 indexed citations
17.
Ehret, Reinhard, Monika Balzer‐Geldsetzer, Jens‐Peter Reese, et al.. (2008). Versorgung von Parkinson-Patienten in neurologischen Schwerpunktpraxen in Berlin (NeuroPa-Studie). Aktuelle Neurologie. 35(S 01).
18.
Walbert, Tobias, Jens‐Peter Reese, & Richard Dodel. (2007). Krankheitskosten neurologischer Erkrankungen in Deutschland. Nervenheilkunde. 26(4). 260–268. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rossella Musolino Breakdown of academic impact, for papers by Giorgio Di Raimondo Breakdown of academic impact, for papers by V. Crespi Breakdown of academic impact, for papers by P. De Carolis Breakdown of academic impact, for papers by Jaime L. Massucci Breakdown of academic impact, for papers by Amy M. Smith Breakdown of academic impact, for papers by Eugene Scharf Breakdown of academic impact, for papers by Katrin Rauen Breakdown of academic impact, for papers by Vida Obese Breakdown of academic impact, for papers by Miya E. Bernson‐Leung
Rankless by CCL
2026